Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Oncology Institute (TOI) Accumulated Depreciation & Amortization (2020 - 2025)

Historic Accumulated Depreciation & Amortization for Oncology Institute (TOI) over the last 6 years, with Q3 2025 value amounting to $5.3 million.

  • Oncology Institute's Accumulated Depreciation & Amortization rose 1598.25% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 1598.25%. This contributed to the annual value of $6.3 million for FY2024, which is 704.92% up from last year.
  • Per Oncology Institute's latest filing, its Accumulated Depreciation & Amortization stood at $5.3 million for Q3 2025, which was up 1598.25% from $3.6 million recorded in Q2 2025.
  • In the past 5 years, Oncology Institute's Accumulated Depreciation & Amortization ranged from a high of $6.3 million in Q4 2024 and a low of $777000.0 during Q1 2021
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $3.0 million (2024), whereas its average is $3.1 million.
  • As far as peak fluctuations go, Oncology Institute's Accumulated Depreciation & Amortization soared by 512.9% in 2021, and later skyrocketed by 3345.76% in 2023.
  • Oncology Institute's Accumulated Depreciation & Amortization (Quarter) stood at $3.3 million in 2021, then skyrocketed by 32.03% to $4.4 million in 2022, then surged by 33.14% to $5.9 million in 2023, then rose by 7.05% to $6.3 million in 2024, then dropped by 15.51% to $5.3 million in 2025.
  • Its Accumulated Depreciation & Amortization stands at $5.3 million for Q3 2025, versus $3.6 million for Q2 2025 and $1.8 million for Q1 2025.